FREDUN PHARMA Q2 FY27 ; NET PROFIT UP 97% AT ₹19 CR (YOY), UP 41% (QOQ)

REVENUE UP 85% AT ₹266 CR (YOY), UP 17% (QOQ) EBITDA UP 97% AT ₹41 CR (YOY), UP 26% (QOQ) MARGINS AT 15.3% VS 14.4% (YOY), 14.2% (QOQ)

FREDUN PHARMACEUTICALS L